Shihong Peng

500 Dongchuan Road
Shanghai, 200241, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.

Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.

Journal: Oncogene

Published: June 05, 2024

Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma.

Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma.

Journal: Genes & diseases

Published: February 11, 2024

Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4.

Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4.

Journal: Genes & diseases

Published: June 08, 2023

A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia.

A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 18, 2023

Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.

Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 26, 2021

Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122.

Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122.

Journal: Frontiers in oncology

Published: January 08, 2021

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer.

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer.

Journal: EMBO molecular medicine

Published: June 09, 2020

Determining the Drug-Like Properties of Ailanthone, a Novel Chinese Medicine Monomer with Anti-CRPC Activity.

Determining the Drug-Like Properties of Ailanthone, a Novel Chinese Medicine Monomer with Anti-CRPC Activity.

Journal: Planta medica

Published: March 14, 2020

Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.

Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 09, 2020

Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.

Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.

Journal: Oncogene

Published: January 26, 2020

Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain.

Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain.

Journal: Cell biology and toxicology

Published: November 07, 2019

A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.

A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 04, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026